Quick Answer
Aura Biosciences, Inc. reported Earnings Per Share Diluted of $1.76 (loss) per share for the year ending 2025.
- Aura Biosciences, Inc. showed a decrease of -0.6% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Aura Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $28.53 (loss) per share | Q3 2021: $28.33 (loss) per share | Q1 2022: $0.44 (loss) per share | Q2 2022: $0.46 (loss) per share | Q3 2022: $0.54 (loss) per share | Q1 2023: $0.46 (loss) per share | Q2 2023: $0.48 (loss) per share | Q3 2023: $0.48 (loss) per share | Q1 2024: $0.40 (loss) per share | Q2 2024: $0.41 (loss) per share | Q3 2024: $0.42 (loss) per share | Q1 2025: $0.55 (loss) per share | Q2 2025: $0.47 (loss) per share | Q3 2025: $0.40 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Aura Biosciences, Inc.'s Earnings Per Share Diluted has grown by 80.3%.
- Historical annual values: Fiscal year 2025: $1.76 (loss) per share | Fiscal year 2024: $1.75 (loss) per share | Fiscal year 2023: $1.93 (loss) per share | Fiscal year 2022: $1.96 (loss) per share | Fiscal year 2021: $8.95 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: